# Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy

> **NCT03450421** · NA · UNKNOWN · sponsor: **Actamax Surgical Materials LLC** · enrollment: 152 (estimated)

## Conditions studied

- Uterine Fibroid

## Interventions

- **DEVICE:** Actamax™Adhesion Barrier

## Key facts

- **NCT ID:** NCT03450421
- **Lead sponsor:** Actamax Surgical Materials LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2019-11
- **Final completion:** 2024-07
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2018-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03450421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03450421, "Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03450421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*